{"schema_version":"secwatch.filing_event.v1","accession":"0000896622-24-000018","form_type":"8-K","ticker":"ATR","cik":"0000896622","company_name":"APTARGROUP, INC.","filed_at":"2024-04-25T23:59:59+00:00","discovered_at":"2026-05-14T18:03:22.370007+00:00","generated_at":"2026-06-03T09:00:21.998865+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Aptar Q1 EPS $1.23 ($1.26 adj) up 50% (31% adj); revenue $915M +6%","bullets":["Reported net income $83M (+52%); adjusted EBITDA $179M (+16%).","Pharma core sales +13% driven by proprietary drug delivery systems; Beauty core -1%, Closures core +1%.","Q2 2024 adjusted EPS guidance $1.30-$1.38; tax rate 22-24%.","Quarterly dividend of $0.41/share payable May 16 to holders of record April 25; $12M in share repurchases.","Lower tax rate of 20.6% vs 25.6% prior year contributed $0.07 EPS benefit."],"urls":{"canonical":"https://secwatch.observer/filing/0000896622-24-000018","json":"https://secwatch.observer/filing/0000896622-24-000018.json","markdown":"https://secwatch.observer/filing/0000896622-24-000018.md","text":"https://secwatch.observer/filing/0000896622-24-000018.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/896622/000089662224000018/0000896622-24-000018-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/896622/000089662224000018/atr-20240425.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-03T09:00:21.998865+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"34feffe71d81556c7189f14bd10b72dd9c355756","claim":"APTARGROUP, INC. reported the quarter ended March 31, 2024 results: revenue $915 million, net income $83 million, EPS $1.23. Guidance reaffirmed.","evidence_excerpt":"year quarter, driven by improved operational performance and cost management efforts First Quarter Results For the quarter ended March 31, 2024, reported sales increased 6% to $915 million compared to $860 million in the prior year. Core sales, excluding the impact from changes in currency exchange rates and acquisitions, increased 5%. First Quarter Segment Sales","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/896622/000089662224000018/0000896622-24-000018-index.htm","confidence":0.98,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the quarter ended March 31, 2024"},{"label":"Revenue","value":"$915 million"},{"label":"Net income","value":"$83 million"},{"label":"EPS","value":"$1.23"},{"label":"Guidance","value":"reaffirmed"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}